Genomic Cancer Panel And Profiling Market Forecast Highlights A $15.44 Billion Opportunity For Industry Participants
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Genomic Cancer Panel And Profiling Market Forecast: Value Set To Climb From $11.17 Billion To $15.44 Billion
The genomic cancer panel and profiling market size has demonstrated robust growth in recent years. It will grow from $10.28 billion in 2025 to $11.17 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. This historical expansion is primarily attributable to factors such as an increase in cancer prevalence, progress in sequencing technologies, the broadening of oncology diagnostics, enhanced funding for genomic research, and the escalating adoption of precision medicine.
The genomic cancer panel and profiling market is anticipated to experience substantial growth over the coming years. Projections indicate it will reach $15.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This expansion during the forecast period is driven by factors such as the increasing use of companion diagnostics, the rising adoption of liquid biopsy, the incorporation of AI into genomic analysis, the proliferation of oncology screening programs, and the creation of more affordable sequencing platforms. Key developments expected in this period include the wider acceptance of multi-gene cancer panels, the growing application of next-generation sequencing, the broadening of liquid biopsy testing, the escalating need for personalized oncology solutions, and the seamless integration of genomic data into clinical decision-making processes.
Get A Free Sample Report With In-Depth Market Insights:
Genomic Cancer Panel And Profiling Market Growth Momentum: What Factors Are Shaping Demand?
The genomic cancer panel and profiling market is projected to expand in the future due to an increasing incidence of cancer. Cancer is a disease characterized by the uncontrolled proliferation and dissemination of abnormal cells throughout the body. The rise in cancer cases is attributable to an aging global population, where a longer life expectancy correlates with an elevated probability of developing cancer. Genomic cancer panels and profiling are instrumental in oncology care by identifying genetic mutations and biomarkers, facilitating personalized treatment strategies, and enhancing early detection and monitoring. For instance, in January 2024, according to the American Cancer Society, a U.S.-based nonprofit organization, around 20 million new cancer cases were reported globally in 2022, resulting in 9.7 million deaths; primarily driven by population growth, the global cancer burden is forecasted to increase to 35 million cases by 2050. Therefore, the growing incidence of cancer will stimulate the growth of the genomic cancer panel and profiling market.
Genomic Cancer Panel And Profiling Market Segmentation And Category Overview
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
Genomic Cancer Panel And Profiling Market Trends Redefining Industry Growth
Leading firms within the genomic cancer panel and profiling market are prioritizing innovations such as next-generation sequencers to enhance the accuracy, speed, and comprehensiveness of cancer diagnostics, thereby facilitating more personalized treatment decisions. Next-generation sequencers represent sophisticated DNA sequencing methods that allow for swift and extensive examination of genetic material for pinpointing mutations, variations, and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, introduced QIAseq panels tailored for use with next-generation sequencers, which facilitate thorough genomic profiling through the analysis of over 700 genes. These panels serve both research and clinical applications, with the objective of enhancing cancer diagnostics and treatment strategies.
Genomic Cancer Panel And Profiling Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
View The Full Genomic Cancer Panel And Profiling Market Report:
Genomic Cancer Panel And Profiling Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
